SMARCA1 and cancer: During TC progression and due to cancer genomic instability across more dedifferentiated TC histologies, the prevalence of mutations in genes linked to SWI/SNF chromatin remodeling complex and the PI3K/AKT/mTOR, MAPK, and JAK/STAT pathways increased [61].